The Medicare Advantage Utilization Management Committee

Medicare Advantage plans design their own utilization-management programs, which is why authorization requirements differ from plan to plan in a way they do not under Original Medicare. What is less widely known is that the design is not unconstrained. An MA organization that uses utilization-management policies and procedures, including prior authorization, must establish a utilization-management committee led by the plan's medical director.

For a practice, the value is not in knowing that a committee exists. It is that the regulation states what the committee is allowed to approve. That converts a plan's authorization rule from something that simply is, into something that had to satisfy stated conditions — and conditions can be examined.

The composition requirements are about clinical judgment and independence rather than administration. The committee must:

• Include a majority of members who are practicing physicians.
• Include at least one practicing physician who is independent and free of conflict relative to the MA organization and the MA plan.
• Include at least one practicing physician who is an expert regarding care of elderly or disabled individuals.
• Include members representing various clinical specialties — the regulation gives primary care and behavioral health as examples — so that a wide range of conditions is adequately considered when the plan's utilization-management policies are developed.

The committee also has to document the process by which it determined that those conditions were met, including how an objective party decides whether a disclosed financial interest is a conflict, and how any resulting recusals are managed.

At least annually, the committee reviews the policies and procedures for all utilization management the plan uses, including prior authorization. That review has to consider the services the utilization management applies to, the coverage decisions and guidelines that apply in Traditional Medicare — including national and local coverage determinations and the law — and relevant current clinical guidelines.

Then comes the constraint. The committee may approve only utilization-management policies and procedures that satisfy all of the following.

Coverage criteria within federal limits

The policy must use or impose coverage criteria that comply with 42 CFR 422.101(b). That is the paragraph requiring an MA organization to follow national coverage determinations, the general coverage and benefit conditions in Traditional Medicare law, and local contractor coverage decisions — and permitting internal coverage criteria only where Medicare's own criteria are not fully established, on stated evidentiary conditions.

Prior-authorization policies within the prior-authorization rule

Where the policy is a prior-authorization policy, it must comply with 42 CFR 422.138, which limits what prior-authorization processes may be used for and provides that an approved authorization generally cannot be reversed later on medical-necessity grounds.

Consistency with the physician-participation standard

The policy must comply with the standard at 42 CFR 422.202(b)(1) governing consultation with contracting physicians on the plan's medical policy, quality improvement, and medical management procedures.

Medical-necessity criteria within the medical-necessity rule

The policy must apply and rely on medical-necessity criteria that comply with 42 CFR 422.101(c)(1) — the paragraph that governs medical-necessity determinations and bars denying basic benefits on coverage criteria the section does not permit.

Finally, the committee must document in writing the reason for its decisions about the development of utilization-management policies, and make that documentation available to CMS on request. The audience for that record is CMS rather than a practice — but it means the reasoning behind a requirement is supposed to exist somewhere in writing.

The Contract Year 2027 Medicare Advantage final rule, published on 6 April 2026 and effective 1 June 2026, removed three of the committee's requirements. All three concerned a health equity analysis of prior authorization that had been added in April 2024.

CMS gave its reasons in the rule. It stated that the requirements were implemented on the basis of health-equity initiatives that have since been revoked by executive order, that they increased regulatory burden, and that its own position had changed — that the analysis is not the best vehicle for obtaining baseline data on prior-authorization use, and that it would pursue that information through interoperability efforts and other data-collection mechanisms instead. CMS acknowledged commenters who argued the opposite, and responded that it did not consider the burden minimal and did not believe the analysis would meaningfully strengthen oversight.

What the removed paragraphs would have produced was a published, plan-level view of how a Medicare Advantage plan uses prior authorization: the share of standard requests approved and denied, the share approved after appeal, the share where the review timeframe was extended and the request was then approved, the equivalent figures for expedited requests, and the average and median time between submission and decision — reported separately for enrollees with and without the specified social risk factors, and posted in a machine-readable file anyone could download without an account.

What survives is the part that was always more useful in an individual dispute. The committee still cannot approve a policy that imposes coverage criteria outside what 42 CFR 422.101(b) permits, or that applies medical-necessity criteria outside 42 CFR 422.101(c)(1). Where a plan denies a basic benefit on an internal rule in circumstances where Medicare's own criteria are fully established, the objection is not that the rule is unreasonable — it is that the rule was not one the committee was permitted to approve.

1. 01

   Read the plan's published coverage criteria first

   Where an MA plan relies on internal coverage criteria, 42 CFR 422.101(b) requires it to publish those criteria along with the evidence considered and the rationale. That publication requirement was not touched by this rule, and it is a more direct source for an individual denial than any aggregate analysis was.
2. 02

   Separate the standard from the process

   A denial can fail on the criterion applied or on how the review was run. The committee rules speak to the first. The prior-authorization rule at 42 CFR 422.138 and the organization-determination and appeal rules speak to the second.
3. 03

   Note that an approval is generally not reversible

   Where an MA organization has approved an item or service through a prior authorization, a pre-service determination, or a concurrent determination, it generally may not later deny coverage for lack of medical necessity, and may not reopen the decision except for good cause or on reliable evidence of fraud or similar fault.
4. 04

   Take the removal duty seriously in a contract conversation

   The obligation to remove utilization management from services that no longer warrant it is a standing one. It is not an appeal argument for a single claim, but it is a legitimate thing to raise where a plan maintains an authorization requirement on a service that has become routine.